Craft

Advanced
LIDDS

LIDDS

Stock Price

KR0.1

2024-10-29

Market Capitalization

KR16.4 M

2024-10-29

LIDDS Summary

Company Summary

Overview
LIDDS is a company developing pharmaceutical products for cancer and other diseases. It offers NZ-2HOF for prostate cancer, NZ-DTX for lung cancer and solid tumors, NZ-DOX for solid tumors, NZ-IO, an antibody-based immunotherapy, NZ-STING for immuno-oncology, and NZ-BELINA for breast cancer.
Type
Public
Status
Active
Founded
2015
HQ
Uppsala, SE | view all locations
Website
https://liddspharma.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Jan Törnell

    Jan Törnell, Chairman of the Board

    • Maria Forss

      Maria Forss, Board Member

      • Daniel Lifveredson

        Daniel Lifveredson, Board Member

        • Anders Bjartell

          Anders Bjartell, Board Member

          LocationsView all

          1 location detected

          • Uppsala, Uppsala län HQ

            Sweden

            Virdings allé 32B

          LIDDS Financials

          Summary Financials

          Net income (Q3, 2025)
          (kr891.0K)
          Cash (Q3, 2025)
          kr1.7M
          EBIT (Q3, 2025)
          (kr876.0K)

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX